<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Testosterone on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/testosterone/</link>
    <description>Recent content in Testosterone on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Feb 2026 07:59:03 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/testosterone/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated?</title>
      <link>https://cluster-site.onrender.com/posts/medcity-pivot-podcast-should-testosterone-replacement-therapy-be-less-regulated/</link>
      <pubDate>Sun, 22 Feb 2026 14:07:00 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/medcity-pivot-podcast-should-testosterone-replacement-therapy-be-less-regulated/</guid>
      <description>• Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance The post</description>
    </item>
  </channel>
</rss>
